Penn-developed Approach Could Limit Toxicity of CAR T Cell Therapy in Acute Myeloid Leukemia – Newswise (press release)
|
Penn-developed Approach Could Limit Toxicity of CAR T Cell Therapy in Acute Myeloid Leukemia
Newswise (press release) Newswise — PHILADELPHIA – A new approach pioneered at the University of Pennsylvania’s Abramson Cancer Center may provide a new path towards treating Acute Myeloid Leukemia (AML) with CAR T cells. To treat AML, investigators have to target a … |
Medical Xpress |
New approach could limit toxicity of CAR T therapy in acute myeloid leukemia
Medical Xpress A new approach pioneered at the University of Pennsylvania’s Abramson Cancer Center may provide a new path towards treating Acute Myeloid Leukemia (AML) with CAR T cells. To treat AML, investigators have to target a specific protein—CD33—that’s … |
FOX 5 Atlanta |
Gene therapy may reduce need for blood transfusions
FOX 5 Atlanta ATLANTA – Each year, about 5 million Americans undergo a blood transfusion. The procedure is used to replace blood lost in surgery and accidents, and to help people with certain illnesses. For Rahul Kapoor’s life, blood transfusions are a monthly lifeline. |